PubMed · 2003 · 16 citations · 0 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionExtracellular MatrixMalignant NeoplasmsMolecular Tumor ProfilingTumor InvasionMatrix Metalloproteinase Gene ExpressionMatrix Metalloproteinase ImagingMatrix Metalloproteinase InhibitorsMatrix Metalloproteinase ProcessingMatrix MetalloproteinasesProtein Expression LevelsTumor Invasion AssessmentWestern Blot Analysis
We have conducted serial studies on the role of matrix metalloproteinases (MMPs), especially MMP-9, in tumor invasion and metastasis. In 9 human carcinoma cell lines derived from lung, prostate and melanoma, we found, by zymography and Western blot, that the expression levels of MMP-2 and MMP-9 correlated well with their invasive as well as metastatic abilities both in vitro and in nude mice. When anti-sense MMP-9 cDNA was introduced into WM451, a highly metastatic human melanoma cell line with high expression level of MMP-9, a significant down-regulation of MMP-9 protein expression was found. Meanwhile, the number of cells passing through Matrigel-coated membrane (in vitro invasion assay) and spontaneous metastases to lymph nodes and lungs were significantly reduced. Furthermore, when tissue inhibitors of metalloproteinases-1, -2 or -3 (TIMP-1, TIMP-2 or TIMP-3) cDNAs were individually transtected into metastatic cancer cells, remarkable inhibition of invasion and metastasis were also noticed in each group. These results demonstrate that either up-regulation of TIMPs or down-regulation of MMPs could significantly inhibit the expression of malignant phenotypes, suggesting the important role MMP-9 plays in tumor invasion and metastasis.